Company: KOYNU
Filing Date: 2025-07-31
Form Type: S-1/A
Source: 0001829126-25-005627
Chunk: 222

Company: CSLM Digital Asset Acquisition Corp III, Ltd
Filing Date: 2025-07-31
Form: S-1/A
Chunk 222
---
 over-allotment option is exercised
during this offering. The purchase price per founder share was determined by dividing the amount of cash contributed to the Company by
the number of founder shares issued. Our Sponsor has committed, pursuant to a Securities Transfer Agreement that will close immediately
prior to effectiveness of the registration statement of which this prospectus forms a part, to transfer 20,000 founder shares (or 100,000
in the aggregate) to each of the Company’s director nominees, Christopher Bradley, Brian Rudick, Mathew August, Danel Calvillo
Armendariz and Dr. Jim Kyung Soo Liew, for the sum of $0.003 per share. Prior to the initial investment of $25,000 by our Sponsor, the
Company had no assets, tangible or intangible. Our initial shareholders will collectively own 25% of our issued and outstanding shares
after this offering (assuming they do not purchase any units in this offering and excluding any shares underlying the private units).
If we increase or decrease the size of this offering, we will effect a capitalization or share repurchase or redemption or other appropriate
mechanism, as applicable, with respect to our founder shares immediately prior to the consummation of this offering in such amount as
to maintain the number of founder shares, on an as-converted basis, at 25% of our issued and outstanding ordinary shares upon the consummation
of this offering (excluding any shares underlying the private units). The Class A ordinary shares issuable upon conversion of our founder
shares may ultimately result in material dilution to our public shareholders due to the anti-dilution rights of our founder shares that
may result in an issuance of Class A ordinary shares on a greater than one-to-one basis upon conversion. In connection with this offering,
up to 1,000,000 founder shares are subject to surrender for no consideration depending on the extent to which the underwriter’s
over-allotment option is exercised during this offering; and an aggregate of 100,000 of which will be transferred pursuant to a Securities
Transfer Agreement, to the Company’s director nominees, Christopher Bradley, Brian Rudick, Mathew August, Danel Calvillo Armendariz
and Dr. Jim Kyung Soo Liew, for the sum of $0.003 per share. Our Sponsor paid a nominal price for the founder shares and, accordingly,
you will experience immediate and substantial dilution upon the purchase of our ordinary shares. Our Sponsor